Cholinesterase inhibitor use is associated with increased plasma levels of anti-Abeta 1–42 antibodies in Alzheimer's disease patients-Reference-Cited by-同舟云学术

Cholinesterase inhibitor use is associated with increased plasma levels of anti-Abeta 1–42 antibodies in Alzheimer's disease patients

Published:2010-12 Issue:3 Volume:486 Page:193-196
ISSN:0304-3940
Container-title:Neuroscience Letters
language:en
Short-container-title:Neuroscience Letters

Author:

Conti Elisa,Galimberti Gloria,Tremolizzo Lucio,Masetto Alessandro,Cereda Diletta,Zanchi Clara,Piazza Fabrizio,Casati Marco,Isella Valeria,Appollonio Ildebrando,Ferrarese Carlo

Publisher

Elsevier BV

Subject

General Neuroscience

Reference38 articles.

1. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease;Bard;Nat. Med.,2000

2. Immune response to Abeta-peptides in peripheral blood from patients with Alzheimer's disease and control subjects;Baril;Neurosci. Lett.,2004

3. Pharmacological treatment of Alzheimer's Disease;Bianchetti;Aging Clin. Exp. Res.,2006

4. Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's disease;Britschgi;Proc. Natl. Acad. Sci. U.S.A.,2009

5. Novel donepezil-based inhibitors of acetyl- and butyrylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation;Camps;J. Med. Chem.,2008

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clearance of interstitial fluid (ISF) and CSF (CLIC) group‐part of Vascular Professional Interest Area (PIA), updates in 2022‐2023. Cerebrovascular disease and the failure of elimination of Amyloid‐β from the brain and retina with age and Alzheimer's disease: Opportunities for therapy;Alzheimer's & Dementia;2023-10-28

2. Association of Microglial Activation With Spontaneous ARIA-E and CSF Levels of Anti-Aβ Autoantibodies;Neurology;2022-08-08

3. Comparative Study of Rivastigmine and Galantamine on the Transgenic Drosophila Model of Alzheimer's Disease;SSRN Electronic Journal;2022

4. Comparative study of rivastigmine and galantamine on the transgenic Drosophila model of Alzheimer's disease;Current Research in Pharmacology and Drug Discovery;2022

5. Spontaneous ARIA-like Events in Cerebral Amyloid Angiopathy–Related Inflammation;Neurology;2021-09-16